Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-007171
Filing Date
2019-02-05
Accepted
2019-02-05 11:07:59
Documents
1
Period of Report
2018-11-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6911
  Complete submission text file 0001209191-19-007171.txt   8253
Mailing Address 1701 TRINITY STREET SUITE 3.322 AUSTIN TX 78712
Business Address 1701 TRINITY STREET SUITE 3.322 AUSTIN TX 78712 512-708-0155
Genprex, Inc. (Issuer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 17406 PAVAROSO STREET BOCA RATON FL 33496
Business Address
Friedman David E. (Reporting) CIK: 0001735757 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38244 | Film No.: 19566727